Source author record

Minsuk Kim

Minsuk Kim appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record

Catalog footprint

What is connected

1works
1topics
1close collaborators

Actions

Connect this record

Log in to claim

Research graph

See the researcher in context

Open full explorer

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

1 published item(s)

preprint2022arXiv

A simple and efficient model for epidemic control on multiplex networks

When an unprecedented infectious disease with high mortality and transmissibility emerges, immediate usage of vaccines or medicines is hardly available. Thus, many health authorities rely on non-pharmaceutical interventions through traceable fixed contacts. However, in reality, there is an additional type of transmission routes to the regular and fixed contacts: the random anonymous infection cases where non-pharmaceutical interventions are hardly feasible. In our study, such realistic situations are implemented by the susceptible-infected-recovered model with isolation on multiplex networks. The multiplex networks are composed of a fixed interaction layer and a layer with time-varying random interactions to represent the different types of disease spreading routes. The multiplex networks represent the combinations of the quenched disorder and annealed disorder. Here, we suggest a preemptive isolation protocol which isolates the second nearest neighbors of the hospitalized individuals and compare it with one of the most popular protocol adopted by many health organizations over the globe. From numerical simulations we find that our preemptive measure significantly reduces both the final epidemic size and the number of the isolated per unit time. Our finding suggests a better non-pharmaceutical intervention which can be adopted to various types of diseases even though the contact tracing is only partially available.